Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 503

1.

Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study.

Gadgeel SM, Lukas RV, Goldschmidt J, Conkling P, Park K, Cortinovis D, de Marinis F, Rittmeyer A, Patel JD, von Pawel J, O'Hear C, Lai C, Hu S, Ballinger M, Sandler A, Gandhi M, Fehrenbacher L.

Lung Cancer. 2019 Feb;128:105-112. doi: 10.1016/j.lungcan.2018.12.017. Epub 2018 Dec 19.

PMID:
30642441
2.

Long-term survival in patients with advanced non-small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study.

von Pawel J, Bordoni R, Satouchi M, Fehrenbacher L, Cobo M, Han JY, Hida T, Moro-Sibilot D, Conkling P, Gandara DR, Rittmeyer A, Gandhi M, Yu W, Matheny C, Patel H, Sandler A, Ballinger M, Kowanetz M, Park K.

Eur J Cancer. 2019 Jan;107:124-132. doi: 10.1016/j.ejca.2018.11.020. Epub 2018 Dec 17.

PMID:
30562710
3.

Closure methods in gastroschisis.

Petrosyan M, Sandler AD.

Semin Pediatr Surg. 2018 Oct;27(5):304-308. doi: 10.1053/j.sempedsurg.2018.08.009. Epub 2018 Aug 28. Review.

PMID:
30413261
4.

Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1).

Kowanetz M, Zou W, Gettinger SN, Koeppen H, Kockx M, Schmid P, Kadel EE 3rd, Wistuba I, Chaft J, Rizvi NA, Spigel DR, Spira A, Hirsch FR, Cohen V, Smith D, Boyd Z, Miley N, Flynn S, Leveque V, Shames DS, Ballinger M, Mocci S, Shankar G, Funke R, Hampton G, Sandler A, Amler L, Mellman I, Chen DS, Hegde PS.

Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10119-E10126. doi: 10.1073/pnas.1802166115. Epub 2018 Oct 8.

5.

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.

Horn L, Mansfield AS, Szczęsna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, Reck M, Mok T, Lam S, Shames DS, Liu J, Ding B, Lopez-Chavez A, Kabbinavar F, Lin W, Sandler A, Liu SV; IMpower133 Study Group.

N Engl J Med. 2018 Dec 6;379(23):2220-2229. doi: 10.1056/NEJMoa1809064. Epub 2018 Sep 25.

PMID:
30280641
6.

Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study.

Gandara DR, von Pawel J, Mazieres J, Sullivan R, Helland Å, Han JY, Ponce Aix S, Rittmeyer A, Barlesi F, Kubo T, Park K, Goldschmidt J, Gandhi M, Yun C, Yu W, Matheny C, He P, Sandler A, Ballinger M, Fehrenbacher L.

J Thorac Oncol. 2018 Dec;13(12):1906-1918. doi: 10.1016/j.jtho.2018.08.2027. Epub 2018 Sep 11.

PMID:
30217492
7.

Videographic Assessment of the Quality of EMS to ED Handoff Communication During Pediatric Resuscitations.

Sumner BD, Grimsley EA, Cochrane NH, Keane RR, Sandler AB, Mullan PC, O'Connell KJ.

Prehosp Emerg Care. 2019 Jan-Feb;23(1):15-21. doi: 10.1080/10903127.2018.1481475. Epub 2018 Aug 30.

PMID:
30118642
8.

Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab.

Gandara DR, Paul SM, Kowanetz M, Schleifman E, Zou W, Li Y, Rittmeyer A, Fehrenbacher L, Otto G, Malboeuf C, Lieber DS, Lipson D, Silterra J, Amler L, Riehl T, Cummings CA, Hegde PS, Sandler A, Ballinger M, Fabrizio D, Mok T, Shames DS.

Nat Med. 2018 Sep;24(9):1441-1448. doi: 10.1038/s41591-018-0134-3. Epub 2018 Aug 6.

PMID:
30082870
9.

Safety and clinical activity of atezolizumab monotherapy in metastatic non-small-cell lung cancer: final results from a phase I study.

Horn L, Gettinger SN, Gordon MS, Herbst RS, Gandhi L, Felip E, Sequist LV, Spigel DR, Antonia SJ, Balmanoukian A, Cassier PA, Liu B, Kowanetz M, O'Hear C, Fassò M, Grossman W, Sandler A, Soria JC.

Eur J Cancer. 2018 Sep;101:201-209. doi: 10.1016/j.ejca.2018.06.031. Epub 2018 Aug 1.

PMID:
30077125
10.

Congenital paraesophageal hernia: Contemporary results and outcomes of laparoscopic approach to repair in symptomatic infants and children.

Petrosyan M, Shah AA, Chahine AA, Guzzetta PC, Sandler AD, Kane TD.

J Pediatr Surg. 2018 Jul 20. pii: S0022-3468(18)30445-7. doi: 10.1016/j.jpedsurg.2018.07.008. [Epub ahead of print]

PMID:
30072216
11.

A System for Managing Staff and Quality of Dementia Care in Assisted Living Facilities.

Simmons SF, Coelho CS, Sandler A, Schnelle JF.

J Am Geriatr Soc. 2018 Aug;66(8):1632-1637. doi: 10.1111/jgs.15463. Epub 2018 Jul 18.

PMID:
30019756
12.

Patient-Reported Outcomes in OAK: A Phase III Study of Atezolizumab Versus Docetaxel in Advanced Non-Small-cell Lung Cancer.

Bordoni R, Ciardiello F, von Pawel J, Cortinovis D, Karagiannis T, Ballinger M, Sandler A, Yu W, He P, Matheny C, Felizzi F, Rittmeyer A.

Clin Lung Cancer. 2018 Sep;19(5):441-449.e4. doi: 10.1016/j.cllc.2018.05.011. Epub 2018 May 31.

13.

Comparison of children diagnosed with cerebral palsy in a private cord blood bank to an epidemiological sample.

Mazonson P, Kane M, Colberg K, Harris H, Brown H, Mohr A, Santas C, Sandler A.

Res Dev Disabil. 2018 Sep;80:153-160. doi: 10.1016/j.ridd.2018.06.011. Epub 2018 Jul 14.

14.

Recent progress in therapeutic antibodies for cancer immunotherapy.

Lee A, Sun S, Sandler A, Hoang T.

Curr Opin Chem Biol. 2018 Jun;44:56-65. doi: 10.1016/j.cbpa.2018.05.006. Epub 2018 Jun 7. Review.

PMID:
29885949
15.

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.

Socinski MA, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Kelsch C, Lee A, Coleman S, Deng Y, Shen Y, Kowanetz M, Lopez-Chavez A, Sandler A, Reck M; IMpower150 Study Group.

N Engl J Med. 2018 Jun 14;378(24):2288-2301. doi: 10.1056/NEJMoa1716948. Epub 2018 Jun 4.

16.

Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria.

Bonomi P, Blumenthal G, Ferris AS, Stewart DJ, Selig WKD, Krug LM, Allen J, Ison G, Langer CJ, Melemed A, Odogwu L, Basu Roy U, Sandler A.

J Thorac Oncol. 2018 Jun;13(6):748-751. doi: 10.1016/j.jtho.2018.02.013. No abstract available.

PMID:
29793646
17.

Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer.

Fehrenbacher L, von Pawel J, Park K, Rittmeyer A, Gandara DR, Ponce Aix S, Han JY, Gadgeel SM, Hida T, Cortinovis DL, Cobo M, Kowalski DM, De Marinis F, Gandhi M, Danner B, Matheny C, Kowanetz M, He P, Felizzi F, Patel H, Sandler A, Ballinger M, Barlesi F.

J Thorac Oncol. 2018 Aug;13(8):1156-1170. doi: 10.1016/j.jtho.2018.04.039. Epub 2018 May 17. Erratum in: J Thorac Oncol. 2018 Nov;13(11):1800.

PMID:
29777823
18.

FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients With NSCLC.

Spigel DR, Chaft JE, Gettinger S, Chao BH, Dirix L, Schmid P, Chow LQM, Hicks RJ, Leon L, Fredrickson J, Kowanetz M, Sandler A, Funke R, Rizvi NA.

J Thorac Oncol. 2018 Nov;13(11):1733-1742. doi: 10.1016/j.jtho.2018.05.004.

PMID:
29775807
19.

A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non-Small Cell Lung Cancer Based on Early Tumor Kinetics.

Claret L, Jin JY, Ferté C, Winter H, Girish S, Stroh M, He P, Ballinger M, Sandler A, Joshi A, Rittmeyer A, Gandara D, Soria JC, Bruno R.

Clin Cancer Res. 2018 Jul 15;24(14):3292-3298. doi: 10.1158/1078-0432.CCR-17-3662. Epub 2018 Apr 23.

PMID:
29685883
20.

Changes in Autonomic Tone in Premature Infants Developing Necrotizing Enterocolitis.

Al-Shargabi T, Reich D, Govindan RB, Shankar S, Metzler M, Cristante C, McCarter R, Sandler AD, Said M, Plessis AD.

Am J Perinatol. 2018 Sep;35(11):1079-1086. doi: 10.1055/s-0038-1639339. Epub 2018 Apr 2.

PMID:
29609189
21.

Ostomy in continuity: A novel approach for the management of children with complex short bowel syndrome.

Sehgal S, Sandler AD, Alfred Chahine A, Mohan P, Torres C.

J Pediatr Surg. 2018 Oct;53(10):1989-1995. doi: 10.1016/j.jpedsurg.2018.02.059. Epub 2018 Mar 4.

PMID:
29602547
22.

A Quality Improvement System to Manage Feeding Assistance Care in Assisted-Living.

Simmons SF, Coelho CS, Sandler A, Schnelle JF.

J Am Med Dir Assoc. 2018 Mar;19(3):262-269. doi: 10.1016/j.jamda.2017.12.012.

PMID:
29402650
23.

PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease.

Srinivasan P, Wu X, Basu M, Rossi C, Sandler AD.

PLoS Med. 2018 Jan 29;15(1):e1002497. doi: 10.1371/journal.pmed.1002497. eCollection 2018 Jan.

24.

Diffusion tensor imaging and ventricle volume quantification in patients with chronic shunt-treated hydrocephalus: a matched case-control study.

Tan K, Meiri A, Mowrey WB, Abbott R, Goodrich JT, Sandler AL, Suri AK, Lipton ML, Wagshul ME.

J Neurosurg. 2018 Dec 1;129(6):1611-1622. doi: 10.3171/2017.6.JNS162784.

PMID:
29350598
25.

Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration.

Zaatiti H, Abdallah J, Nasr Z, Khazen G, Sandler A, Abou-Antoun TJ.

Int J Oncol. 2018 Mar;52(3):787-803. doi: 10.3892/ijo.2018.4236. Epub 2018 Jan 4.

26.

Molecular and functional analysis of anchorage independent, treatment-evasive neuroblastoma tumorspheres with enhanced malignant properties: A possible explanation for radio-therapy resistance.

Abou-Antoun TJ, Nazarian J, Ghanem A, Vukmanovic S, Sandler AD.

PLoS One. 2018 Jan 3;13(1):e0189711. doi: 10.1371/journal.pone.0189711. eCollection 2018.

27.

MYCN Amplification Is Associated with Repressed Cellular Immunity in Neuroblastoma: An In Silico Immunological Analysis of TARGET Database.

Zhang P, Wu X, Basu M, Dong C, Zheng P, Liu Y, Sandler AD.

Front Immunol. 2017 Nov 3;8:1473. doi: 10.3389/fimmu.2017.01473. eCollection 2017.

28.

Proposed clinical pathway for nonoperative management of high-grade pediatric pancreatic injuries based on a multicenter analysis: A pediatric trauma society collaborative.

Naik-Mathuria BJ, Rosenfeld EH, Gosain A, Burd R, Falcone RA Jr, Thakkar R, Gaines B, Mooney D, Escobar M, Jafri M, Stallion A, Klinkner DB, Russell R, Campbell B, Burke RV, Upperman J, Juang D, St Peter S, Fenton SJ, Beaudin M, Wills H, Vogel A, Polites S, Pattyn A, Leeper C, Veras LV, Maizlin I, Thaker S, Smith A, Waddell M, Drews J, Gilmore J, Armstrong L, Sandler A, Moody S, Behrens B, Carmant L; the Pancreatic Trauma Study Group (PTSG) Collaborators:.

J Trauma Acute Care Surg. 2017 Oct;83(4):589-596. doi: 10.1097/TA.0000000000001576.

PMID:
28930953
29.

The Clinical Functional Impairment Scale Development.

Sandler A, Wright ME, Denslow S.

J Dev Behav Pediatr. 2017 Oct;38(8):619-626. doi: 10.1097/DBP.0000000000000478.

PMID:
28746060
30.

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).

Peters S, Gettinger S, Johnson ML, Jänne PA, Garassino MC, Christoph D, Toh CK, Rizvi NA, Chaft JE, Carcereny Costa E, Patel JD, Chow LQM, Koczywas M, Ho C, Früh M, van den Heuvel M, Rothenstein J, Reck M, Paz-Ares L, Shepherd FA, Kurata T, Li Z, Qiu J, Kowanetz M, Mocci S, Shankar G, Sandler A, Felip E.

J Clin Oncol. 2017 Aug 20;35(24):2781-2789. doi: 10.1200/JCO.2016.71.9476. Epub 2017 Jun 13.

31.

Managing Person-Centered Dementia Care in an Assisted Living Facility: Staffing and Time Considerations.

Simmons SF, Coelho CS, Sandler A, Shah AS, Schnelle JF.

Gerontologist. 2018 Jul 13;58(4):e251-e259. doi: 10.1093/geront/gnx089.

PMID:
28575376
32.

Raising the pressure: Hemodynamic effects of splanchnic nerve stimulation.

Fudim M, Yalamuri S, Herbert JT, Liu PR, Patel MR, Sandler A.

J Appl Physiol (1985). 2017 Jul 1;123(1):126-127. doi: 10.1152/japplphysiol.00069.2017. Epub 2017 Mar 30.

33.

Prospects and progress of atezolizumab in non-small cell lung cancer.

Vansteenkiste J, Wauters E, Park K, Rittmeyer A, Sandler A, Spira A.

Expert Opin Biol Ther. 2017 Jun;17(6):781-789. doi: 10.1080/14712598.2017.1309389. Epub 2017 Mar 28. Review.

PMID:
28335643
34.

Online Information-Seeking Behaviors of Parents of Children With ADHD.

Sage A, Carpenter D, Sayner R, Thomas K, Mann L, Sulzer S, Sandler A, Sleath B.

Clin Pediatr (Phila). 2018 Jan;57(1):52-56. doi: 10.1177/0009922817691821. Epub 2017 Feb 9.

PMID:
28183190
35.

The "11 O'clock Heel First" technique for microvascular end-to-side anastomosis.

Hegazy A, Adel MF, Abd-Allah F, Al-Shamy H, Elbassiouny A, Amin SM, El Samadoni A, Sandler A, Biswas A.

Neurol India. 2017 Jan-Feb;65(1):69-72. doi: 10.4103/0028-3886.198207.

36.

Youth Views on Communication About ADHD and Medication Adherence.

Sleath B, Carpenter DM, Sayner R, Thomas K, Mann L, Sage A, Sulzer SH, Sandler AD.

Community Ment Health J. 2017 May;53(4):438-444. doi: 10.1007/s10597-016-0078-3. Epub 2017 Jan 10.

PMID:
28074407
37.

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.

Rittmeyer A, Barlesi F, Waterkamp D, Park K, Ciardiello F, von Pawel J, Gadgeel SM, Hida T, Kowalski DM, Dols MC, Cortinovis DL, Leach J, Polikoff J, Barrios C, Kabbinavar F, Frontera OA, De Marinis F, Turna H, Lee JS, Ballinger M, Kowanetz M, He P, Chen DS, Sandler A, Gandara DR; OAK Study Group.

Lancet. 2017 Jan 21;389(10066):255-265. doi: 10.1016/S0140-6736(16)32517-X. Epub 2016 Dec 13. Erratum in: Lancet. 2017 Apr 8;389(10077):e5.

PMID:
27979383
38.

PS01.62: Long-Term Safety and Clinical Activity of Atezolizumab Monotherapy in Metastatic NSCLC: Final Results from a Phase Ia Study: Topic: Medical Oncology.

Gordon MS, Herbst RS, Horn L, Soria JC, Gandhi L, Felip E, Sequist L, Spigel DR, Antonia SJ, Balmanoukian A, Cassier P, Liu B, Kowanetz M, O'Hear C, Fassò M, Sandler A, Gettinger SN.

J Thorac Oncol. 2016 Nov;11(11S):S309-S310. doi: 10.1016/j.jtho.2016.09.097. Epub 2016 Oct 28. No abstract available.

39.

PS01.57: IMpower133: a Phase I/III Study of 1L Atezolizumab with Carboplatin and Etoposide in Patients with Extensive-Stage SCLC: Topic: Medical Oncology.

Horn L, Reck M, Mok T, Johnson ML, Tang X, Lam S, Waterkamp D, Lopez-Chavez A, Sandler A, Giacconne G, Liu SV.

J Thorac Oncol. 2016 Nov;11(11S):S305-S306. doi: 10.1016/j.jtho.2016.09.092. Epub 2016 Oct 28. No abstract available.

40.

PS01.56: IMpower110: Phase III Trial Comparing 1L Atezolizumab with Chemotherapy in PD-L1-Selected Chemotherapy-Naive NSCLC Patients: Topic: Medical Oncology.

Herbst RS, De Marinis F, Jassem J, Lam S, Mocci S, Sandler A, Lopez-Chavez A, Deng Y, Giaccone G, Spigel DR.

J Thorac Oncol. 2016 Nov;11(11S):S304-S305. doi: 10.1016/j.jtho.2016.09.091. Epub 2016 Oct 28. No abstract available.

41.

PS01.55: IMpower010: Phase III Study of Atezolizumab vs BSC After Adjuvant Chemotherapy in Patients with Completely Resected NSCLC: Topic: Medical Oncology.

Vallieres E, Felip E, Altorki N, Zhou C, Zuo Y, Howland M, Xia F, Hoang T, Sandler A, Wakelee H.

J Thorac Oncol. 2016 Nov;11(11S):S304. doi: 10.1016/j.jtho.2016.09.090. Epub 2016 Oct 28. No abstract available.

42.

PS01.53: First-Line Atezolizumab Plus Chemotherapy in Chemotherapy-Naive Patients with Advanced NSCLC: A Phase III Clinical Program: Topic: Medical Oncology.

Jotte RM, Socinski MA, Reck M, Papadimitrakopoulou V, West HJ, Mok T, Sandler A, Mocci S, Coleman S, Asakawa T, Cappuzzo F.

J Thorac Oncol. 2016 Nov;11(11S):S302-S303. doi: 10.1016/j.jtho.2016.09.088. Epub 2016 Oct 28. No abstract available.

43.

ORAL01.04: Phase II Trial of Atezolizumab for Patients with PD-L1-Selected Advanced NSCLC (BIRCH): Updated Efficacy and Exploratory Biomarker Results: Topic: Medical Oncology.

Wakelee H, Patel JD, Heist R, Balmanoukian A, Besse B, Felip E, Carcereny Costa E, Chow LQ, Koczywas M, Garassino MC, Christoph D, Toh CK, Johnson ML, Chaft J, Kurata T, Qiu J, Kowanetz M, Coleman S, Mocci S, Sandler A, Gettinger SN, Peters S.

J Thorac Oncol. 2016 Nov;11(11S):S251-S252. doi: 10.1016/j.jtho.2016.09.009. Epub 2016 Oct 28. No abstract available.

44.

A Review of the Fundamental Principles and Applications of Solution Blow Spinning.

Daristotle JL, Behrens AM, Sandler AD, Kofinas P.

ACS Appl Mater Interfaces. 2016 Dec 28;8(51):34951-34963. doi: 10.1021/acsami.6b12994. Epub 2016 Dec 14.

45.

Solution blow spun polymer: A novel preclinical surgical sealant for bowel anastomoses.

Kern NG, Behrens AM, Srinivasan P, Rossi CT, Daristotle JL, Kofinas P, Sandler AD.

J Pediatr Surg. 2017 Aug;52(8):1308-1312. doi: 10.1016/j.jpedsurg.2016.11.044. Epub 2016 Dec 5.

46.

Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma.

Cano-Mejia J, Burga RA, Sweeney EE, Fisher JP, Bollard CM, Sandler AD, Cruz CRY, Fernandes R.

Nanomedicine. 2017 Feb;13(2):771-781. doi: 10.1016/j.nano.2016.10.015. Epub 2016 Nov 5.

PMID:
27826115
47.

Modeling and simulation of maintenance treatment in first-line non-small cell lung cancer with external validation.

Han K, Claret L, Sandler A, Das A, Jin J, Bruno R.

BMC Cancer. 2016 Jul 13;16:473. doi: 10.1186/s12885-016-2455-2.

48.

Surgical management of esophageal achalasia: Evolution of an institutional approach to minimally invasive repair.

Petrosyan M, Khalafallah AM, Guzzetta PC, Sandler AD, Darbari A, Kane TD.

J Pediatr Surg. 2016 Oct;51(10):1619-22. doi: 10.1016/j.jpedsurg.2016.05.015. Epub 2016 May 31.

PMID:
27292598
49.

VBP15, a novel dissociative steroid compound, reduces NFκB-induced expression of inflammatory cytokines in vitro and symptoms of murine trinitrobenzene sulfonic acid-induced colitis.

Damsker JM, Conklin LS, Sadri S, Dillingham BC, Panchapakesan K, Heier CR, McCall JM, Sandler AD.

Inflamm Res. 2016 Sep;65(9):737-43. doi: 10.1007/s00011-016-0956-8. Epub 2016 Jun 3.

PMID:
27261270
50.

The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway.

Stevenson DA, Schill L, Schoyer L, Andresen BS, Bakker A, Bayrak-Toydemir P, Burkitt-Wright E, Chatfield K, Elefteriou F, Elgersma Y, Fisher MJ, Franz D, Gelb BD, Goriely A, Gripp KW, Hardan AY, Keppler-Noreuil KM, Kerr B, Korf B, Leoni C, McCormick F, Plotkin SR, Rauen KA, Reilly K, Roberts A, Sandler A, Siegel D, Walsh K, Widemann BC.

Am J Med Genet A. 2016 Aug;170(8):1959-66. doi: 10.1002/ajmg.a.37723. Epub 2016 May 7.

Supplemental Content

Loading ...
Support Center